EHP-5CRO: EHP-5 in Preoperative Assessment in Women With Endometriosis

Sponsor
University of Zagreb (Other)
Overall Status
Unknown status
CT.gov ID
NCT04491305
Collaborator
(none)
100
1
12
8.3

Study Details

Study Description

Brief Summary

There is no validated tool in quality-of-life assessment of women with endometriosis in Croatia. First aim is to validate Endometriosis Health Profile-5 (EHP-5) before implementing this questionnaire in clinical practice. After validation, we will prospectively follow women with endometriosis through whole process - pre- and postoperatively.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Surgically treated women with endometriosis and confirmed diagnosis

Detailed Description

There is no validated tool in quality-of-life assessment of women with endometriosis in Croatia. First aim is to validate Endometriosis Health Profile-5 (EHP-5) before implementing this questionnaire in clinical practice. After validation, we will prospectively follow women with endometriosis through whole process - pre- and postoperatively, including comparison with rASRM and Enzian score which are already established in our Clinic.

We will try to identify correlation between EHP-5 score and surgical findings and to provide better insight in quality of life consideration of women with endometriosis particularly in Croatia. Since we are tertiary referral centre with almost 250 operative procedures which include ovarian, pelvic and/or extra pelvic endometriosis, we believe that this study will bring new tool not only for preoperative assessment but postoperative surveillance.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Implementation of Endometriosis Health Profile-5 (EHP-5) in Croatian Gynecological Practice for Preoperative Assessment in Women With Endometriosis
Anticipated Study Start Date :
Aug 1, 2020
Anticipated Primary Completion Date :
Aug 1, 2021
Anticipated Study Completion Date :
Aug 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Women with pathohistological confirmation

Women aged between 18 and 50 with surgically proven endometriosis.

Procedure: Surgically treated women with endometriosis and confirmed diagnosis
Women with indication for surgery or diagnostic laparoscopy will be enrolled in study.

Outcome Measures

Primary Outcome Measures

  1. EHP-5 score can predict extent of surgical procedure [Intraoperative time]

    Bigger overall EHP-5 score will be successful predictor of required surgical intervention

Secondary Outcome Measures

  1. EHP-5 score in postoperative surveillance [Postoperative routine surveillance at two different time points - 6 weeks and 6 months after operation]

    We assume that EHP-5 score can be used as a postoperative surveillance indicator

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged between 18 and 50 years; symptoms of endometriosis (pelvic pain, dyspareunia, dysmenorrhea) for at least 6 months or previously verified primary sterility; pathohistological confirmation of diagnosis after surgical treatment or indicated diagnostic laparoscopy; fluent and literate in Croatian language; ability to independently understand the questions in the questionnaires
Exclusion Criteria:
  • pregnant women; cognitive impairment or intellectual disability; neurological disorders (e.g. epilepsy, Parkinson disease, multiple sclerosis, cerebrovascular insult); lack of independent mobility and polytraumatic patients; diagnosed vulvodynia and active vulvovaginitis; ongoing urinary tract infection; any form of prior conservative and/or surgical treatment for endometriosis; lack of informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Hospital Centre Zagreb, Croatia Zagreb Croatia 10 000

Sponsors and Collaborators

  • University of Zagreb

Investigators

  • Principal Investigator: Mislav Mikuš, MD, University Hospital Center Zagreb, Croatia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mislav Mikuš, MD, University of Zagreb
ClinicalTrials.gov Identifier:
NCT04491305
Other Study ID Numbers:
  • PetrovaZg
First Posted:
Jul 29, 2020
Last Update Posted:
Jul 29, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mislav Mikuš, MD, University of Zagreb
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2020